Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) CEO Daniel O'Day sold 15,000 shares of the business's stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $147.90, for a total transaction of $2,218,500.00. Following the sale, the chief executive officer owned 566,683 shares in the company, valued at $83,812,415.70. This trade represents a 2.58% decrease in their ownership of the stock. The transacti…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.